issued
on 02 Apr 2024
Last Applicant/ Owned by
Calle Arquitecto Mora, 5 - 4
Valencia
ES
46010
Serial Number
97761526 filed on 19th Jan 2023
Registration Number
N/A
Correspondent Address
Christopher J. Day
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Providing scientific analysis and informational reports based upon results of laboratory testing in the field of genetics; providing online computer databases featuring scientific information based on aggregated results of genotyping; application service provider (asp) featuring software for providing access to multiple databases that contain aggregated results of genotyping; application service pRead More
Providing scientific analysis and informational reports based upon results of laboratory testing in the field of genetics; providing online computer databases featuring scientific information based on aggregated results of genotyping; application service provider (asp) featuring software for providing access to multiple databases that contain aggregated results of genotyping; application service provider (asp) featuring software for use in data management, data storage, data analysis, report generation, user identification, and membership identification, all in the fields of genetics and genetic testing; scientific research in the fields of genetics, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, and ancestry; Consulting services in the fields of biotechnology and pharmaceutical research and development; providing information about medical and scientific research; development of non-downloadable computer software for scientific analysis of genetic sequences
Medical diagnostic apparatus for measuring genetic predisposition to diseases; Medical diagnostic apparatus for measuring an individual's genetic drug compatibility for use in determining an individual's genetic variability on his or her response to certain drugs for the purpose of identifying the most effective drugs, applying the best doses and optimal concentrations of these drugs, avoiding undesirable side effects according to the genetic pattern of each individual; Medical diagnostic apparatus for measuring an individual's genetic personality traits; Medical diagnostic apparatus for measuring an individual's genetic predisposition to well-being-related data, namely the individual's genetic predisposition to their body's response to food and exercise; Medical diagnostic apparatus for measuring an individual's genetic ancestry, namely the individual's paternal and maternal haplogroups, the percentage of Neanderthal DNA in the individual's genetic makeup, and ethnic origin of the individual's ancestors; Medical diagnostic apparatus for testing DNA samples; Kits for use in genetic identity testing and genetic diagnostic testing for medical purposes comprising a saliva collection tube, saliva collection swabs, printed instructions, and mailing packaging for use in DNA testing of humans
No 97761526
No Service Mark
No
No
No
No
No
No
No
No
No
26.11.14 -
Three or more rectangles
26.11.21 -
Rectangles that are completely or partially shaded
The mark consists of the stylized wording "tellmeGen" in dark gray. Above the wording, there are a pattern of colored squares. In the top line, there is a yellow, white, and pink square. In the next line, there is a light turquoise, red, light blue, black, and light gray square. In the next line, there is a dark turquoise, brown, light orange, and dark orange square. In the next line, there is a dark green, purple, and aqua blue square. In the last line is a dark blue square.
| Status Date | Action Taken |
|---|---|
| 02th Apr 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 06th Feb 2024 | PUBLISHED FOR OPPOSITION |
| 06th Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 17th Jan 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 04th Jan 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 07th Dec 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 07th Dec 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 07th Dec 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 20th Oct 2023 | NON-FINAL ACTION WRITTEN |
| 20th Oct 2023 | NON-FINAL ACTION E-MAILED |
